To be part of your patient’s life, they have to first be part of rigorous levels of clinical trials. Our quality and medical parameters bind us into continued state-of-the-art stents that offer lifelong health and wellness.
Evaluation of Novel Ultrathin, Biodegradable Polymer-Coated Tetriflex Sirolimus-Eluting Stent Optimization Using Intravascular Ultrasound (IVUS) in Short Coronary Lesions (<20 mm) vs. Long Coronary Lesions (≥20 mm): Tetriflex IVUS Study
Abstracts of EuroPCR 2022, Scientific Abstract e-Book (Euro22A-POS228).
Intravascular Ultrasound Study
Comparison of neointimal coverage between ultrathin biodegradable polymer-coated sirolimus-eluting stents and durable polymer-coated everolimus-eluting stents: 6 months optical coherence tomography follow-up from the TAXCO study
Catheter Cardiovasc Interv. 2021 Feb 15;97(3):423-430.
Optical Coherence Tomography Study
A randomised controlled trial of the sirolimus-eluting biodegradable polymer ultra-thin Supraflex stent versus the everolimus-eluting biodegradable polymer SYNERGY stent for three-vessel coronary artery disease: rationale and design of the Multivessel TAL
EuroIntervention. 2020 Dec 18;16(12):e997-e1004.
Randomized Controlled Trial
A prospective multicentre randomised all-comers trial to assess the safety and effectiveness of the thin-strut sirolimus-eluting coronary stent SUPRAFLEX: rationale and design of the Thin Strut Sirolimus-eluting Stent in All Comers Population vs Everolimu
Comparison of biodegradable polymer (Everoflex) vs. permanent polymer (Xience Pro) coated everolimus-eluting coronary stent systems in all-comer patient population at a tertiary care hospital - One-year outcome study
Abstract presented at EuroPCR-2017 and published on 16 May 2017 (Euro17A-POS0268).
Comparison of two biodegradable polymer coated, drug-eluting coronary stents paclitaxel vs. sirolimus, with 6-years clinical follow-up: BIOPRESS(BIOdegradable Polymer Registry Smt Stents) Infinnium vs. Supralimus
Journal of Cardiology and Therapeutics. 2014;2(1):12-20.
Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents: 1-year results of the PAINT trial
Catheter Cardiovasc Interv. 2009 Nov 1;74(5):665-673.
Randomized Controlled Trial
Prospective evaluation of the feasibility, safety, and efficacy of Cocoon Duct Occluder for transcatheter closure of large patent ductus arteriosus: A single-center study with short- and medium-term follow-up results
Anatol J Cardiol. 2017 Nov;18(5):321-327.
Transcatheter trans-aortic retrograde approach for the closure of perimembranous ventricular septal defects using Cocoon [Amplatzer Duct Occluder I like] device – An initial experience from a single centre